| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
kelch like family member 33 | 1.000 | 0.077 | 1.0E-05 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
small glutamine rich tetratricopeptide repeat containing beta | 1.000 | 0.077 | 4.1E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
suppressor APC domain containing 1 | 0.931 | 0.154 | 1.8E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
ribosomal protein S9 | 0.780 | 0.154 | 0.88 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2015 | 2015 | ||||||||
|
activating transcription factor 6 beta | 0.839 | 0.192 | 3.1E-07 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
leukocyte immunoglobulin like receptor B3 | 0.805 | 0.269 | 3.1E-06 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2017 | ||||||||
|
MAX dimerization protein MLX | 0.722 | 0.346 | 0.11 |
|
disease | 0.340 | None | 1.000 | 6 | 1 | 2013 | 2018 | ||||||||
|
eukaryotic elongation factor, selenocysteine-tRNA specific | 0.751 | 0.385 | 2.7E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
follistatin like 3 | 0.695 | 0.423 | 0.69 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
EHMT2 and SLC44A4 antisense RNA 1 | 0.780 | 0.462 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
ripply transcriptional repressor 2 | 0.650 | 0.462 | 9.4E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
Aicardi syndrome | 0.729 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
major histocompatibility complex, class II, DO beta | 0.705 | 0.500 | 1.9E-06 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
proprotein convertase subtilisin/kexin type 5 | 0.659 | 0.538 | 2.5E-12 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
FERM domain containing 4A | 0.650 | 0.538 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
T cell receptor gamma locus | 0.631 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | |||||||||
|
zinc ribbon domain containing 1 antisense, pseudogene | 0.691 | 0.538 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
tubulin alpha 1c | 0.663 | 0.577 | 7.4E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
thymosin beta 10 | 0.641 | 0.577 | 1.8E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
RPL17-C18orf32 readthrough | 0.572 | 0.615 | 0.58 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
NFKB inhibitor like 1 | 0.653 | 0.615 | 2.6E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
spermatogenesis associated 2 | 0.556 | 0.615 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
proline rich coiled-coil 2A | 0.656 | 0.654 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
LY6/PLAUR domain containing 4 | 0.601 | 0.692 | 9.0E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |